Mittie Doyle - 10 Dec 2025 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Chief Medical Officer
Signature
/s/ Christopher Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
10 Dec 2025
Net transactions value
-$4,153
Form type
4
Filing time
12 Dec 2025, 16:18:52 UTC
Previous filing
08 Aug 2025
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle Mittie Chief Medical Officer C/O AVALO THERAPEUTICS, INC., 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE /s/ Christopher Sullivan, by Power of Attorney 12 Dec 2025 0001918845

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Tax liability $4,153 -1,013 -22% $4.10 3,622 10 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,622 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.